← Open Payments lookup

LADAN HAKIMJAVADI: Open Payments

NPI 1144849415 · CHARLESTOWN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$909 in 35 payments from 10 companies in 2025. Trend: 2023 $542 · 2024 $814 · 2025 $909

Food & beverage: $909
CompanyPaymentsAmount
Merck Sharp & Dohme LLC11$291
AstraZeneca Pharmaceuticals LP6$207
PFIZER INC.3$71
Amgen Inc.3$70
Bayer Healthcare Pharmaceuticals Inc.3$65
Novartis Pharmaceuticals Corporation3$57
Alnylam Pharmaceuticals Inc.2$52
E.R. Squibb & Sons, L.L.C.2$51
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Medtronic, Inc.1$22

Products named: VERQUVO, LOKELMA, Repatha, Kerendia, LEQVIO, FARXIGA, AMVUTTRA, VYNDAQEL.

Industry payments across MA — which companies pay providers there.